Envista Holdings Corporation Common Stock (NY:NVST)

23.27 -0.19 (-0.81%)

Delayed Quote Updated: 1:17 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Envista Holdings Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

5 Insightful Analyst Questions From Envista’s Q1 Earnings Call

May 13, 2026

Envista’s first quarter results saw sales increase driven by strong growth across orthodontics, diagnostics, and consumables, supported by new product launch...

Via StockStory

Envista (NVST) Q1 2026 Earnings Transcript ↗

May 08, 2026

Envista (NVST) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics Artificial Intelligence Economy

NVST Q1 Deep Dive: Strong Revenue Growth, Market Cautious on Macro and Tariffs

May 08, 2026

Dental products company Envista Holdings (NYSE:NVST) announced better-than-expected revenue in Q1 CY2026, with sales up 14.4% year on year to $705.5 million....

Via StockStory

Topics Economy World Trade

Envista Holdings Corp (NYSE:NVST) Beats Q1 Estimates But Market Reaction Remains Muted ↗

May 06, 2026

Via Chartmill

Envista Holdings Corp (NYSE:NVST) Stock Surges Over 13% After Q4 2025 Earnings Beat ↗

February 05, 2026

Via Chartmill

Envista (NYSE:NVST) Posts Better-Than-Expected Sales In Q1 CY2026

May 06, 2026

Dental products company Envista Holdings (NYSE:NVST) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 14.4% year on year to $705.5 million...

Via StockStory

Envista (NVST) Q1 Earnings: What To Expect

May 04, 2026

Dental products company Envista Holdings (NYSE:NVST) will be reporting results this Wednesday after market hours. Here’s what investors should know. Envista ...

Via StockStory

CooperCompanies Appoints Paul Keel to its Board of Directors

May 04, 2026

From CooperCompanies

Via GlobeNewswire

Envista (NYSE:NVST): Strongest Q4 Results from the Dental Equipment & Technology Group

April 26, 2026

Looking back on dental equipment & technology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Envista (NYSE:NVST) and its...

Via StockStory

Dental Equipment & Technology Stocks Q4 Recap: Benchmarking Dentsply Sirona (NASDAQ:XRAY)

April 26, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how dental equipment ...

Via StockStory

Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know

April 17, 2026

What Happened? A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and ener...

Via StockStory

Topics Economy

Greater Canal Efficiency. Less Waste. Introducing ZenSeal(TM) Pro with ZenSave(TM) Tips from Kerr Dental

April 16, 2026

Via ACCESS Newswire

Kerr Dental Launches Demi(TM) Pro - The Light That Moves With You

April 16, 2026

Via ACCESS Newswire

Dental Equipment & Technology Stocks Q4 Recap: Benchmarking Align Technology (NASDAQ:ALGN)

April 01, 2026

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...

Via StockStory

3 Cash-Producing Stocks We’re Skeptical Of

April 01, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Via StockStory

3 Stocks Under $50 That Fall Short

March 26, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Via StockStory

1 Healthcare Stock with Exciting Potential and 2 We Ignore

March 18, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...

Via StockStory

Envista, Baxter, Artivion, Dentsply Sirona, and Cigna Stocks Trade Down, What You Need To Know

March 06, 2026

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

Via StockStory

Topics Economy

2 Small-Cap Stocks Worth Investigating and 1 We Avoid

March 05, 2026

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...

Via StockStory

1 Surging Stock for Long-Term Investors and 2 We Question

February 22, 2026

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro...

Via StockStory

3 Profitable Stocks That Concern Us

February 19, 2026

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

3 Hyped Up Stocks We Think Twice About

February 18, 2026

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.

Via StockStory

Danaher Corporation (DHR): Navigating the Bioprocessing Thaw and the Masimo Pivot

February 17, 2026

As of February 17, 2026, Danaher Corporation (NYSE: DHR) finds itself at a pivotal juncture in its multi-decade evolution. Once the darling of the "compounding" investment community, the Washington,...

Via Finterra

Topics Artificial Intelligence Earnings Supply Chain

3 Reasons to Avoid NVST and 1 Stock to Buy Instead

February 15, 2026

Envista’s 39.5% return over the past six months has outpaced the S&P 500 by 33.6%, and its stock price has climbed to $28.97 per share. This was partly due to its solid quarterly results, and the...

Via StockStory

Topics Stocks

5 Must-Read Analyst Questions From Envista’s Q4 Earnings Call

February 12, 2026

Envista’s fourth quarter results were met with a notably positive market reaction, reflecting stronger-than-anticipated revenue and profit growth. Management attributed this performance to broad-based...

Via StockStory

Topics Earnings

1 Cash-Producing Stock with Impressive Fundamentals and 2 We Avoid

February 10, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

NVST Q4 Deep Dive: Broad-Based Growth and Margins Lift Outlook for 2026

February 06, 2026

Dental products company Envista Holdings (NYSE:NVST) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 15% year on year to $750.6 million. Its non-GAAP profit of $0.38...

Via StockStory

Why Envista (NVST) Stock Is Trading Up Today

February 06, 2026

Shares of dental products company Envista Holdings (NYSE:NVST) jumped 13.5% in the morning session after the company reported fourth-quarter financial results that significantly beat Wall Street's...

Via StockStory

Topics Artificial Intelligence Supply Chain

The market is filled with gapping stocks in Friday's session. ↗

February 06, 2026

Via Chartmill

Envista (NYSE:NVST) Beats Expectations in Strong Q4 CY2025

February 05, 2026

Dental products company Envista Holdings (NYSE:NVST) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 15% year on year to $750.6 million. Its non-GAAP profit of $0.38 per share was...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.